LipoScience focused on changing the way heart disease, diabetes and other metabolic diseases are assessed and managed.
Business Model:
Revenue: $42.3M
Employees: 201-500
LipoScience was acquired by
LabCorp.
The acquisition happend on 2014-09-25.
Details of the transaction were not public
Address: 2500 Sumner Blvd
City: Raleigh
State: NC
Zip: 27616
Country: US
LipoScience focused on changing the way heart disease, diabetes and other metabolic diseases are assessed and managed.
Contact Phone:
+19192121999
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
2/1/2013
IPO Valuation:
$124M
Ticker Symbol:
LPDX
IPO Price:
$9/share
Amount Raised:
$39M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2013 | IPO | $45M | 8/2003 | Series E | 6 | $15M |
Piper Jaffray U.S. Bancorp Invesco A. M. Pappas &a; Associates GE Capital Three Arch Partners Piper Jaffray U.S. Bancorp Invesco |
8/2006 | Series F | 7 | $13M |
Varian Camden Partners GE Capital Invesco Pappas Ventures SightLine Partners Three Arch Partners Camden Partners GE Capital Invesco Pappas Ventures SightLine Partners Three Arch Partners Varian |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|